Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

NCT00099619 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide/insulin glargine
DRUG: insulin glargine/exenatide

Sponsor

AstraZeneca

Collaborators

[object Object]